Safety and Feasibility of Argatroban, Recombinant Tissue Plasminogen Activator, and Intra-Arterial Therapy in Stroke (ARTSS-IA Study)

Medicine and Dentistry

• Endovascular Surgery 100%
• Apoplexy 100%
• Alteplase 100%
• Argatroban 100%
• Intraarterial Drug Administration 100%
• Infusion 20%
• Brain Ischemia 20%
• Blood Clot Lysis 20%
• Cerebral Hemorrhage 20%
• Artery Occlusion 10%
• Arm 10%
• Thrombin 10%
• Middle Cerebral Artery 10%
• Partial Thromboplastin Time 10%
• Internal Carotid Artery 10%
• Recanalization 10%
• Modified Rankin Scale 10%
• Posterior Cerebral Artery 10%
• Large Vessel Occlusion 10%

Keyphrases

• Endovascular Therapy 100%
• Recombinant Tissue Plasminogen Activator (rt-PA) 100%
• Argatroban 100%
• Intra-arterial Therapy 100%
• Cerebral Ischemia 20%
• Thrombolysis 20%
• Symptomatic Intracerebral Hemorrhage (sICH) 20%
• Complications of Therapy 20%
• Time Metrics 20%
• Middle Cerebral Artery 10%
• Arterial Occlusion 10%
• Activated Partial Thromboplastin Time (aPTT) 10%
• Randomized Trial 10%
• Bolus 10%
• Reperfusion 10%
• Recanalization 10%
• Stroke Onset 10%
• Stroke Patients 10%
• Internal Carotid Artery 10%
• Modified Rankin Scale 10%
• Safety Study 10%
• Posterior Cerebral Artery 10%
• Therapy Treatment 10%
• Therapy Time 10%
• Thrombin Inhibition 10%
• Single-arm Feasibility Study 10%
• Intracranial Large Vessel Occlusion 10%

Neuroscience

• Cerebrovascular Accident 100%
• Alteplase 100%
• Argatroban 100%
• Brain Ischemia 25%
• Cerebral Hemorrhage 25%
• Middle Cerebral Artery 12%
• Thromboplastin 12%
• Thrombin 12%
• Internal Carotid Artery 12%
• Posterior Cerebral Artery 12%